Status: Closed
Activation Date: 2004FEB10
Closing Date: 2007OCT01
Phase: II
Description: This Protocol is a Laboratory Companion for Southwest Oncology Group Coordinated Trials for Lung Cancer
Eligibility: Only patients previously registered to Southwest Oncology Group lung cancer treatment protocols will be registered to this study.
Objective: To establish a central lung cancer specimen repository to serve as a resource for current and future scientific studies. To utilize the Southwest Oncology Group clinical database to perform clinicopathologic correlation with the results of those studies. To test a new hypotheses as they emerge.
Participation: Open to member centres
Primary Publication Show
Other Publications Show
Inventory
Hide Tissue Samples
| Disease Site | Trial Code | Patients Accrued | Patients - Blocks | Patients - Slides | Patients - Blocks and/or Slides |
| LUNG | BR23C | 8 | 0 | 2 | 2 |
(Core size is 0.6 mm)
Hide
Fluid Samples| Disease Site | Trial Code | Patients Accrued | TMA Blocks | Patients on TMA Blocks |
| LUNG | BR23C | 8 | 0 | 0 |
| Disease Site | Trial Code | Patients Accrued | Patients - Whole Blood | Patients - Cellular Component of Blood | Patients - DNA extracted from Blood | Patients - RNA extracted from Blood | Patients - Plasma | Patients - Serum | Patients - Urine | Patients - Buccal |
| LUNG | BR23C | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |